Fcgamma receptor 1 (CD64), a target beyond cancer
1Fraunhofer Institute for Molecular Biology and Applied Ecology, Department of Pharmacetical Product Development, 52074 Aachen, Germany. Thepen@molbiotech.rwth-aachen.de
Current Pharmaceutical Design
|August 20, 2009
Summary
CD64 immunotoxins effectively eliminate activated macrophages, offering a targeted therapy for chronic inflammatory diseases. This approach minimizes side effects, paving the way for treating non-life-threatening conditions.
Area of Science:
- Immunology
- Pharmacology
- Biotechnology
Background:
- Immunotoxins are potent cell-eliminating agents, historically limited to cancer treatment due to side effects.
- Improvements in immunotoxin design have reduced side effects, enabling broader therapeutic applications.
- Chronic inflammatory disorders involve activated macrophages expressing CD64, contributing to disease progression.
Purpose of the Study:
- To review the efficacy of CD64 immunotoxins in eliminating activated macrophages in animal models of chronic disease.
- To discuss the evolution of immunotoxin technology from chemically linked antibodies to advanced single-chain constructs.
- To evaluate the therapeutic potential of CD64-targeted macrophage elimination in chronic inflammatory conditions.
Main Methods:
- Review of existing data on CD64 immunotoxin efficacy in animal models.
- Discussion of immunotoxin development, including chemically linked and genetically engineered single-chain variants.
- Analysis of the impact of selective macrophage depletion on chronic disease progression.
Main Results:
- Chemically linked immunotoxins demonstrated proof of concept for eliminating activated macrophages.
- Genetically engineered, fully human single-chain immunotoxins show reduced immunogenicity.
- Specific elimination of CD64-expressing macrophages beneficially impacts chronic disease courses.
Conclusions:
- CD64 immunotoxins selectively eliminate disease-driving activated macrophages.
- Targeted macrophage depletion offers a promising therapeutic strategy for chronic inflammatory diseases.
- Advancements in immunotoxin technology enhance safety and efficacy for non-cancerous conditions.
More Related Videos
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.